McKelligon Brian's Form 4 filing
Akoya Biosciences, Inc. (AKYA) · filed Mar 16, 2023
- Accession no.
- 0001104659-23-033335
- Filed
- Mar 16, 2023, 4:20 PM ET
- Trade date
- Mar 14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $45.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McKelligon BrianCIK 0001857447 | Director, Officer (President/CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Common Stock | MOption exerciseAcquired | +5,000 | $0.303 | +$1,515 | 165,000 | Direct | |
| Mar 14, 2023 | Common Stock | SSaleDisposed | −4,774 | $9.14 | −$43,610.49 | 160,226 | Direct | |
| Mar 14, 2023 | Common Stock | SSaleDisposed | −226 | $9.92 | −$2,241.47 | 160,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 333,129 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.